Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings ...

After hours: January 28 at 6:55:04 PM EST Loading Chart for TLPH ...

Rodman & Renshaw analyst Brandon Folkes initiated coverage of Talphera (TLPH) with a Buy rating and $4 price target Invest with Confidence: ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.